Prognostic effect of TCF1 + CD8 + T cell and TOX + CD8 + T cell infiltration in lung adenocarcinoma
Cancer Science · 2024-07 · 115 (7) · 2184-2195
DOI: 10.1111/cas.16177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 09.04.2024. Verfasst von Yao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Adenocarcinoma of Lung, Lung Neoplasms, Hepatocyte Nuclear Factor 1-alpha. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Bethune Charitable Foundation, the Key Research and Development Program of Shandong.
Abstract (Originalsprache)
Recent studies have highlighted the pivotal roles of T cell transcription factors TCF‐1 and TOX in modulating the immune response in cancer, with TCF‐1 maintaining CD8+ T cell stemness and TOX promoting T cell exhaustion. The prognostic significance of these factors in lung adenocarcinoma (LUAD) remains a critical area of investigation. The retrospective study included 191 patients with LUAD who underwent surgery, of whom 83% were in stages II and III. These patients were divided into exploratory ( n = 135) and validation ( n = 56) groups based on the time of diagnosis. Multiplex fluorescence immunohistochemistry was used to examine the infiltration levels of CD8+ T cells, TCF1+ CD8+ T cells, and TOX+ CD8+ T cells. The percentage of CD8+ T cells in tumor was markedly lower than that in stroma ( p < 0.05). In tumor‐draining lymph nodes (TDLNs) invaded by tumor, the proportion of stem‐like TCF1+ CD8+ T cells was significantly decreased ( p < 0.01). Importantly, higher infiltration levels of CD8+ T cells and TCF1+ CD8+ T cells were associated with improved disease‐free survival (DFS) ( p = 0.009 and p = 0.006, respectively) and overall survival (OS) ( p = 0.018 and p = 0.010, respectively). This study underscores the potential of TCF1+ CD8+ T cells as prognostic biomarkers in LUAD, providing insights into the tumor immune microenvironment and guiding future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, C…
- Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences, Jinan, China.
- Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
- Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Jinming Yu, Xiangjiao Meng
Förderung
- National Natural Science Foundation of China
- Beijing Bethune Charitable Foundation
- the Key Research and Development Program of Shandong
- the Natural Science Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, Y., Ma, L., Chen, Y., Yun, W., Yu, J., & Meng, X. (2024). Prognostic effect of TCF1 + CD8 + T cell and TOX + CD8 + T cell infiltration in lung adenocarcinoma. Cancer Science, 115(7), 2184-2195. https://doi.org/10.1111/cas.16177
Vancouver
Wang Y, Ma L, Chen Y, Yun W, Yu J, Meng X. Prognostic effect of TCF1 + CD8 + T cell and TOX + CD8 + T cell infiltration in lung adenocarcinoma. Cancer Science. 2024;115(7):2184-2195. doi:10.1111/cas.16177
BibTeX
@article{Wang2024,
author = {Wang, Yao and Ma, Lin and Chen, Yu and Yun, Wenhua and Yu, Jinming and Meng, Xiangjiao},
title = {Prognostic effect of TCF1 + CD8 + T cell and TOX + CD8 + T cell infiltration in lung adenocarcinoma},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {7},
pages = {2184--2195},
doi = {10.1111/cas.16177}
}
EUVIMED